Å·ÃÀAV

Introduction

Sub-standard and counterfeit medicines are a great threat to patient health and safety as well as the profitability of the UK pharmaceutical industry. This valuable symposium looks at the big issues and current best practice: designing the formulation of medicines for authentication, the steps being taken by the European pharmaceutical industry to implement the European Falsified Medicines Directive as well as the MHRA’s enforcement successes and the role of its Laboratory. The use of modern methods to detect counterfeit medicines in the laboratory includes the use of NMR and MS methods; NIR, Raman and optical imaging methods; and the use of hand-held instruments. The symposium will be introduced by Prof Trevor M Jones CBE.

Useful links

Speakers

• Professor Tony Moffat, UCL School of Pharmacy, London, United Kingdom
• Professor Trevor M Jones CBE, Kings College, London, United Kingdom
• James Gilmore Colorcon, Dartford, United Kingdom
• Mark Jackson MHRA, London, United Kingdom
• Stephen Young MHRA, London, United Kingdom
• Dr Neville Broad NWBSpectroscopy, Sittingbourne, United Kingdom
• Dr Rick Greville ABPI, United Kingdom
• Dr Ian Jones AstraZeneca, Macclesfield, United Kingdom
• Dr Jean-Claude Wolff GSK, Stevenage, United Kingdom

---

Sponsorship & supporting organisations

Royal Pharmaceutical Society and Å·ÃÀAV

Venue

The Å·ÃÀAV

Library, The Å·ÃÀAV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Organised by

Joint Pharmaceutical Analysis Group

Contact information

Amy Le Vannais
Royal Pharmaceutical Society
(44) (0) 20 7572 2326
Contact us by email

---